Correction: EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review

Correction: EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review

Saved in:

Bibliographic Details
Main Authors:	Qiu-yuan Xiang, Min Zuo, Ji-Hao Zhou, Chun Feng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	activated phosphoinositide 3-kinase δ syndrome Epstein-Barr virus diffuse large B-cell lymphoma Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+ DLBCL) inborn error of immunity
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1659197/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi
by: Nathan D. Montgomery, et al.
Published: (2020-01-01)

EBV status has prognostic implication among young patients with angioimmunoblastic T‐cell lymphoma
by: Ahmed E. Eladl, et al.
Published: (2020-01-01)

Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas
by: Ying Li, et al.
Published: (2025-08-01)

Immunological Prevalence of EBV in Rheumatoid Arthritis Iraqi Patients
by: Wafaa Ayad Al-Nuaimy, et al.
Published: (2025-07-01)

HIV-associated lymphomas
by: G. A. Dudina, et al.
Published: (2023-01-01)

Molecular diagnosis of nasopharyngeal carcinoma: Past and future
by: Cheng-Lung Hsu, et al.
Published: (2025-02-01)

Comparison between ELISA and PCR for Detection of Epstein - Barr virus in children with acute cervical lymphadenitis
by: Nazim Khan, et al.
Published: (2024-11-01)

Diffuse large B-cells lymphoma clinical features in patients with hepatitis B and C infection
by: G. I. Storozhakov, et al.
Published: (2022-11-01)

The clinical and laboratory characteristics of infectious mononucleosis caused by the Epstein-Barr virus type 1 in hospitalized children
by: M. I. Popkova, et al.
Published: (2023-04-01)

Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies
by: Allison M. Bock, et al.
Published: (2025-07-01)

Survival and Outcome of Patients with Diffuse Large B-cell Lymphoma According to the Central Nervous System–International Prognostic Index
by: Musa Fares Alzahrani, et al.
Published: (2025-07-01)

Histopathological characteristics of Epstein-Barr virus (EBV)–associated encephalitis and colitis in chronic active EBV infection
by: Betty A Kasimo, et al.
Published: (2025-05-01)

Case Report: From Kaposi’s sarcoma to primary effusive lymphoma
by: Tao Wang, et al.
Published: (2025-08-01)

Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers
by: Seungkyun Woo, et al.
Published: (2025-12-01)

Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas
by: Chu-Yi Chan, et al.
Published: (2025-12-01)

Research progress of oral hairy leukoplakia
by: MO Longhui, LIANG Jing, WANG Jiongke, LIU Tiannan, ZENG Xin
Published: (2025-08-01)

A case of Epstein Barr virus-associated primary squamous cell carcinoma of stomach
by: Yuki Katsura, et al.
Published: (2021-11-01)

IN VITRO CELLULAR RESPONSE TO INTERFERON-α2 IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN-BARR VIRUS
by: L. M. Kurtasova, et al.
Published: (2016-04-01)

Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
by: D. A. Miroshnichenko, et al.
Published: (2020-11-01)

Histone variant H2A.Z cooperates with EBNA1 to maintain Epstein-Barr virus latent epigenome
by: Leonardo Josué Castro-Muñoz, et al.
Published: (2025-08-01)

IN VITRO EFFECTS OF MEVASTATIN AND BIOLOGICAL PREPARATIONS UPON ACTIVATION OF EBV-SPECIFIC CD4+T LYMPHOCYTES FROM THE PATIENTS WITH RHEUMATOID ARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2014-07-01)

Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience
by: TT Valiev, et al.
Published: (2016-10-01)

Testicular diffuse large B-cell lymphoma. Clinical lecture and case report
by: K. B. Lelyavin, et al.
Published: (2023-12-01)

A case of coexistence of hydroa vacciniforme-like lymphoproliferative disorder and Epstein-Barr virus pneumonia
by: Wei Zhang, MD, PhD, et al.
Published: (2025-09-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

CLINICAL-IMMUNOLOGY EFFICIENCY OF CONSERVATIVE TREATMENT OF PATIENTS WITH CHRONIC TONSILLITIS ASSOCIATED WITH EPSTEIN - BARR VIRUS INFECTION
by: A. S. Krasnitskaja, et al.
Published: (2012-05-01)

Epidemiology characteristics of Epstein-Barr virus among children in Hangzhou from 2019 to 2023
by: Chen Lin, et al.
Published: (2025-08-01)

HUMORAL IMMUNE RESPONSES TO EPSTEIN-BARR VIRUS IN PATIENTS WITH PRECANCEROUS GASTRIC LESIONS AND GASTRIC CANCER OF DIFFERENT HISTOTYPES
by: M. V. Vusik, et al.
Published: (2016-11-01)

Recurrent primary pulmonary anaplastic B-cell lymphoma in a 35-year-old patient treated with radical resection: A case report.
by: George Bashour, et al.
Published: (2025-03-01)

Management approaches for primary hepatic lymphoma: 10 year institutional experience with comprehensive literature review
by: Jennifer Ma, et al.
Published: (2025-03-01)

Epstein-Barr virus in Adygeans and Slavs in Russia: virus types, <i>LMP1</i> variants, and malignant tumors
by: K. V. Smirnova, et al.
Published: (2022-10-01)

serologic markers of Epstein-Barr virus reactivation in the conditions of viral encephalitis in young patients
by: O. V. Goleva, et al.
Published: (2015-04-01)

Advancements in the epidemiology of nasopharyngeal carcinoma
by: DU Yun, et al.
Published: (2024-09-01)

The Role of Epstein-Barr Virus in the Pathogenesis of Autoimmune Diseases
by: Natalia Morawiec, et al.
Published: (2025-06-01)

Cytomegalovirus and Epstein-Barr virus infections among Jordanians: seroprevalence and associated factors
by: Hassan M. Kofahi, et al.
Published: (2025-05-01)

КОМПЛЕКСНАЯ ТЕРАПИЯ ЭПШТЕЙНА-БАРР-ВИРУСНОЙ ИНФЕКЦИИ У ДЕТЕЙ
by: Л. В. Крамарь, et al.
Published: (2012-02-01)

Cytotoxic activity of peripheral blood lymphocytes in children with infectious mononucleosis
by: N. R. Slepicheva, et al.
Published: (2009-08-01)

Multi-omics and experimental validation reveal mechanism of compound mylabris capsules in treating diffuse large B-cell lymphoma
by: Cancan Wang, et al.
Published: (2025-07-01)

In Silico Analysis of Dysregulated Genes and Drug Resistance in Epstein-Barr Virus Associated Gastric Cancer
by: Tabassom Sedaghat Anbouhi, et al.
Published: (2023-11-01)